HEPHAISTOS-Pharma
PrivateLast Round
Seed
May 16, 2024
Total Funding Raised
$4.88M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
HEPHAISTOS-Pharma is a biotechnology company developing innovative oncology treatments through a platform that enhances immune responses and transforms cold tumors into targets for effective cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HEPHAISTOS-Pharma Comparables
Compare HEPHAISTOS-Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tallac Therapeutics | 83% | |
| Stimunity | 81% | |
| Ipsen | 78% | |
HEPHAISTOS-Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 16, 2024 |
Key People
Founding team and executive leadership
HEPHAISTOS-Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Seed |
| European Innovation Council Fund | Seed |
| Noshaq | Seed |
| xista science ventures | Seed |
| Elaia Partners | Seed |
| Angels Santé | Seed |
| Femmes Business Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Grew 19% QoQ, from 16 to 19 employees.
- May 16, 2024
$4.88M raised from Elaia Partners and Noshaq.
HEPHAISTOS-Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HEPHAISTOS-Pharma's valuation, stock price, and market status.